Prosecution Insights
Last updated: November 20, 2026
Application No. 18/267,688

SIGNAL ANALYZING APPARATUS, SIGNAL ANALYZING METHOD AND PROGRAM

Final Rejection §101§103
Filed
Jun 15, 2023
Priority
Jan 06, 2021 — nonprovisional of PCTJP2021000209
Examiner
JOHNSON, NICOLE F
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Nippon Telegraph and Telephone Corporation
OA Round
4 (Final)
87%
Grant Probability
Favorable
5-6
OA Rounds
0m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 87% — above average
87%
Career Allowance Rate
1221 granted / 1397 resolved
+17.4% vs TC avg
Moderate +7% lift
Without
With
+7.4%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
38 currently pending
Career history
1450
Total Applications
across all art units

Statute-Specific Performance

§101
9.1%
-30.9% vs TC avg
§103
37.0%
-3.0% vs TC avg
§102
34.5%
-5.5% vs TC avg
§112
10.1%
-29.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1397 resolved cases

Office Action

§101 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claim 8 is rejected under 35 U.S.C 101 because the invention is directed to a judicial exemption without additional elements amounting to significantly more than the exemption. Please see the below 2 Prong Analysis: Step One: Claim 8 recites a signal-analysis method and therefore falls within the statutory category of a process. Step 2A, Prong One: Claim 8 recites “determining a condition of the heart based on information indicating the state of activity of the acquired ion channels.” Under the broadest reasonable interpretation, this limitation encompasses evaluating available ion-channel activity information and forming a judgement concerning the heart’s condition. For example, a person reviewing information indicating normal or abnormal channel activity can make a corresponding assessment of cardiac condition. The limitation does not require a particular calculation or computational procedure for making the assessment. Accordingly, the limitation recites an evaluation of judgement practically performable in the human mind and falls within the mental-process grouping of abstract ideas. See MPEP §2106.04(a). The recitation of a processor performing the determination does not alter the nature of the underlying evaluation. This finding does not depend on treating the specification’s cumulative-distribution-function fitting as mentally performable; claim 8 does not recite the fitting. Step 2A, Prong Two: The additional elements include a processor executing instructions stored in memory; acquisition of cardiac time-series information and candidate channel-activity timing-distribution information; acquisition of ion-channel activity information based on those inputs; and display of that activity information. The initial acquisition steps supply information for the subsequent analysis without specifying a measurement technique or sensor arrangement. The activity-information acquisition limitation identifies its inputs and desired result but does not specify the processing that relates those input to that result. The display presents the resulting information without requiring a particular display arrangement or further technical operation. The processor and memory implement these functions without a specified improvement in their operation. The specification’s stated objective of obtaining additional cardiac information, including the discussion in paragraph [0004], has been considered together with the fitting implementation in paragraphs [0039]-[0040]. Claim 8, however, does not require that implementation or another particular processing mechanism that provides the described improvement. The claimed use of candidate timing-distribution information limits the information considered, but the claim leaves unspecified how that information is used to derive channel activity. Considered as an ordered combination, these elements provide inputs, obtain and present activity information, and perform the recited heart-condition evaluation. They do not integrate the mental process into a practical application. Step 2B: The additional elements, individually and in combination, do not amount to significantly more than the abstract idea. The processor, memory and display perform broadly recited information-handling functions. Paragraph [0064] describes implementation using a CPU and memory connected by a bus and executing a program. The treatment of generic computer implementation and information presentation is further supported by Alice Corp. v. CLS Bank International, 573 U.S. 208, 225-226 (2014), and Electric Power Group, LLC v. Alstrom S.A., 830 F. 3d 1350, 1355-1356 (Fed. Cir. 2016). This finding concerns the generally recited computer functions; it does not assert that the particular physiological information or every disclosed analysis technique is conventional. The requirement to obtain activity information from the specified inputs remains expressed as a desired result, without a particular mechanism supplying an inventive implementation. The ordered combination likewise specifies no additional technical operation beyond providing and presenting information for the evaluation. Accordingly, claim 8 is directed to an abstract idea without significantly more and is not patent eligible. Allowable Subject Matter Claims 2-4, 6-7 & 9-15 are allowed. The following is an examiner’s statement of reasons for allowance: The prior art of record does not teach or suggest the claimed combination in which cardiac ion-channel activity is characterized by fitting cumulative functions representing candidate activity-timing distributions to an acquired electrocardiogram and selecting a distribution based on minimization of the waveform discrepancy. Pak estimates ion-channel conductance characteristics through comparisons of simulated and measured action-potential durations. Passerini models cardiac electrophysiology and adjusts patient-specific parameters using observed cardiac data. Neither reference, alone or in combinations considered, establishes the claimed distribution-based waveform-fitting process for obtaining ion-channel activity information. Claim 9 further constrains that process by relating the difference between two cumulative functions to the R-wave shape. Regarding subject-matter eligibility, the claims, considered as a whole, recite a particular cardiac signal-processing implementation that derives physiological information through the specified fitting operations. These operations implement the disclosed improvement in extracting ion-channel activity information from cardiac waveforms and integrate the mathematical processing into a practical application. Eligibility therefore rests on the claimed processing combination, rather than merely on the use of a processor, display, or cardiac field of user. The dependent claims are allowable at least by virtue of incorporating the limitations of their respective allowable independent claims. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Response to Arguments Applicant’s arguments and the amended claims have been considered. Upon reconsideration of Pak and the additional references, reviewed, the record does not establish that the prior art teaches or suggests obtaining ion-channel activity information from a cardiac biological information together with candidate distributions representing channel-activity timings, as required by claim 8. Accordingly, no rejection of claim 8 under 35 U.S.C. §§ 102 or 103 is made in this action. The prior art determination does not resolve the separate issue of subject-matter eligibility. The disclosed improvement in cardiac signal analysis has been considered. However, claim 8 does not recite the particular cumulative-distribution-function fitting operations described in the specification and recited in other pending independent claims. Instead, claim 8 identifies the information used and the result obtained without specifying the processing mechanism that produces the asserted improvement. The eligibility analysis addresses claim 8 as a whole, including its acquisition of candidate timing-distribution information and its derivation and display of ion-channel activity information. Please see the above action, in which specifies that those limitations do not integrate the recited heart-condition evaluation into a practical application or provide significantly more than the identified abstract idea. Claim 8 therefore remains subject to the §101 rejection set forth above. Applicant’s arguments concerning the rejections under 35 U.S.C. §§101 and 103 have been considered. Regarding §101, cancellations of claims 1 and 5 is acknowledged. Claims 2-4 and 6 have been amended to depend from claim 7 and therefore incorporate its signal-processing limitations. The previous §101 rejection of claims 7 and 9 is made in this action. Applicant’s assertion that new claim 8 should receive he same treatment as claim 7 because it includes similar features is not persuasive. Unlike claim 7, claim 8 does not require fitting candidate cumulative distribution functions to an electrocardiogram waveform and selecting a channel-activity timing distribution through minimization of the waveform difference. Claim 9 likewise expressly requires fitting operations that are absent from claim 8. The claims therefore differ in the processing required to obtain ion-channel activity information. Please see the above action pertaining to the 35 U.S.C. §101 analysis of claim 8. Regarding §103, applicant’s characterization of Pak as limited to the opening and closing of a single ion channel is not adopted. Pak describes multiple ion-channel conductance parameters and estimates patient-specific channel characteristics by comparing simulated and measured action-potential durations. Nevertheless, the previously applied rejection does not adequately establish the claimed use of candidate channel-activity timing distributions-function fitting required by amended claim 7. Accordingly, the previous rejection under §103 over Pak is withdrawn. No rejection of new claim 8 and 9 under §§102 and 103 is made in this action. This prior art determination is separate form the §101 rejection of claim 8. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Passerini et al., (U.S. 10,241,968), discloses patient-specific cardiac electrophysiology modeling, including estimation of ion-channel-related parameters from observed cardiac data. Van Dam Peter et al. (WO 2010/151130) discloses estimation of cardiac activation and recovery timings by comparing simulated and measured electrocardiographic signals. Niederer et al. (US 2019/0298213), discloses selection of cardiac tissue-model parameters by fitting measured activation data to precomputed simulations. These references are pertinent to cardiac signal analysis but are not relied upon in a rejection because the reviewed disclosures do not establish the claimed combination of fitting cumulative functions representing candidate channel-activity timing distributions to an electrocardiogram and deriving ion-channel activity information from the fitting result. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to NICOLE F JOHNSON whose telephone number is (571)270-5040. The examiner can normally be reached Monday-Friday 8:00am-5:00pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Hamaoui can be reached at 571-270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NICOLE F JOHNSON/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Show 3 earlier events
Oct 20, 2025
Applicant Interview (Telephonic)
Oct 22, 2025
Response Filed
Dec 29, 2025
Final Rejection mailed — §101, §103
May 12, 2026
Request for Continued Examination
May 15, 2026
Response after Non-Final Action
May 20, 2026
Non-Final Rejection mailed — §101, §103
Aug 31, 2026
Response Filed
Oct 27, 2026
Final Rejection mailed — §101, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12796998
IDENTIFYING FOCAL SOURCES OF ARRHYTHMIA WITH MULTI ELECTRODE CATHETER
3y 11m to grant Granted Nov 17, 2026
Patent 12797094
UNIBODY RETRIEVAL BASKETS AND METHODS
3y 3m to grant Granted Nov 17, 2026
Patent 12796992
METHOD AND DEVICE FOR THE TECHNICAL SUPPORT OF THE ANALYSIS OF SIGNALS ACQUIRED BY MEASUREMENT, THE SIGNALS HAVING A TIME- AND SPACE-DEPENDENT SIGNAL CHARACTERISTIC
2y 9m to grant Granted Nov 17, 2026
Patent 12797016
Virtual Healthcare Apparatus, Methods And Systems
2y 12m to grant Granted Nov 17, 2026
Patent 12778506
BIOLOGICAL DATA MEASUREMENT SYSTEM
3y 1m to grant Granted Nov 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
87%
Grant Probability
95%
With Interview (+7.4%)
2y 8m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 1397 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month